AprilBio·Hugel·CorestemChemon Surge on Licensing·Earnings·Approval Hopes [K-Bio Pulse] 송영두 2026.05.11 오전 08:00 AprilBio Jumps 12% on U.S. Partner’s IPO Filing; Toolgen, Onconic Surge [K-bio Pulse] 석지헌 2025.10.13 오전 07:39 AprilBio Falls on Insider Sales...Cellbion, NEUROPHET Up[K-Bio Pulse] 김새미 2026.02.11 오전 08:00 AprilBio’s Global Partner Evommune Files for NYSE IPO 석지헌 2025.10.10 오전 10:24 AprilBio Swings from Cold to Hot...Rokit and Hugel Climb on Earnings Strength[K-Bio Pulse] 임정요 2026.02.12 오전 08:00 ToolGen revalued after U.S. EU patent wins[K-Bio Pulse] 김지완 2025.12.30 오전 08:00 IPO 앞둔 에이프릴바이오, 덴마크에 5000억원 규모 기술이전 이광수 2021.10.15 오후 01:41 로딩중..
AprilBio
AprilBio
![AprilBio·Hugel·CorestemChemon Surge on Licensing·Earnings·Approval Hopes [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/05/PS26051100126b.jpg)
![AprilBio Jumps 12% on U.S. Partner’s IPO Filing; Toolgen, Onconic Surge [K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/10/PS25101300100b.jpg)
![AprilBio Falls on Insider Sales...Cellbion, NEUROPHET Up[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26021100303b.jpg)
![AprilBio Swings from Cold to Hot...Rokit and Hugel Climb on Earnings Strength[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26021200278b.jpg)
![ToolGen revalued after U.S. EU patent wins[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/12/PS25123000246b.jpg)
